Sign Up to like & get
recommendations!
1
Published in 2019 at "Current Oncology Reports"
DOI: 10.1007/s11912-019-0777-3
Abstract: Purpose of ReviewDuctal carcinoma in situ (DCIS; intraductal carcinoma) of the breast is commonly found in an asymptomatic woman on routine screening mammography. The purpose of this review is to describe current approaches to the…
read more here.
Keywords:
risk;
carcinoma situ;
breast;
dcis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Pathology Research and Practice"
DOI: 10.1016/j.prp.2017.02.016
Abstract: Abstract Background It is desirable to decrease the underestimation rate of invasion in cases diagnosed as ductal carcinoma in situ (DCIS) in breast core needle biopsy (CNB) in order to determine the appropriate candidates for…
read more here.
Keywords:
carcinoma situ;
invasion;
dcis;
ductal carcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Histopathology"
DOI: 10.1111/his.14804
Abstract: Ductal carcinoma in situ (DCIS) of the breast is a non‐invasive tumour that has the potential to progress to invasive ductal carcinoma (IDC). Thus, it represents a treatment dilemma: alone it does not present a risk…
read more here.
Keywords:
ductal carcinoma;
dcis breast;
carcinoma situ;
situ dcis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Medical Decision Making"
DOI: 10.1177/0272989x17729358
Abstract: Background. Ductal carcinoma in situ (DCIS) can be a precursor to invasive breast cancer. Since the advent of screening mammography in the 1980’s, the incidence of DCIS has increased dramatically. The value of screen detection…
read more here.
Keywords:
carcinoma situ;
cisnet;
dcis;
ductal carcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051303
Abstract: Simple Summary Specific drug targets for breast ductal carcinoma in situ (DCIS) remain elusive, despite increasing disease prevalence and burden to healthcare services. Estrogen receptor (ER)-negative HER2-positive DCIS, associated with the poorest patient prognosis, is…
read more here.
Keywords:
ductal carcinoma;
carcinoma situ;
situ dcis;
dcis ... See more keywords